Literature DB >> 21329956

Papillomavirus capsid proteins mutually impact structure.

Horng-Shen Chen1, Michael J Conway, Neil D Christensen, Samina Alam, Craig Meyers.   

Abstract

We studied a panel of mutant viruses containing wild-type and chimeric capsid HPV16 and HPV18 proteins. The mutant capsid protein expression, genome amplification, and episomal maintenance were comparable with the wild-type virus. However, the chimeric viruses varied in their titers from wild-type. We show that the intertypical mutant chimeric capsid viruses, that L2 affects the structure of L1 and that L1 affects the structure of L2 in the virion. These effects were measured using a panel of conformation-dependent neutralizing L1 MAbs and an L2 capsid surface peptide derived neutralizing antibody. These data suggest that variation of one capsid gene not only affects its own structure and antigenicity, but also affects the structure and antigenicity of the other capsid protein. Implications of our data suggest that for the continued effectiveness of a vaccine, variation in both capsid proteins need to be considered and not just the protein the vaccine is directed against.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21329956      PMCID: PMC3060953          DOI: 10.1016/j.virol.2011.01.018

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  46 in total

1.  The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle.

Authors:  Sigrid C Holmgren; Nicole A Patterson; Michelle A Ozbun; Paul F Lambert
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

2.  Maturation of papillomavirus capsids.

Authors:  Christopher B Buck; Cynthia D Thompson; Yuk-Ying S Pang; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

3.  Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA.

Authors:  C Meyers; T J Mayer; M A Ozbun
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Human papillomavirus 16 minor capsid protein L2 helps capsomeres assemble independently of intercapsomeric disulfide bonding.

Authors:  Yoshiyuki Ishii; Saori Ozaki; Keiko Tanaka; Tadahito Kanda
Journal:  Virus Genes       Date:  2005-12       Impact factor: 2.332

5.  Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells.

Authors:  C Volpers; P Schirmacher; R E Streeck; M Sapp
Journal:  Virology       Date:  1994-05-01       Impact factor: 3.616

6.  Common neutralization epitope in minor capsid protein L2 of human papillomavirus types 16 and 6.

Authors:  K Kawana; H Yoshikawa; Y Taketani; K Yoshiike; T Kanda
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

7.  Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2.

Authors:  Diana V Pastrana; Ratish Gambhira; Christopher B Buck; Yuk-Ying S Pang; Cynthia D Thompson; Timothy D Culp; Neil D Christensen; Douglas R Lowy; John T Schiller; Richard B S Roden
Journal:  Virology       Date:  2005-07-05       Impact factor: 3.616

8.  Interaction of tSNARE syntaxin 18 with the papillomavirus minor capsid protein mediates infection.

Authors:  Ioannis Bossis; Richard B S Roden; Ratish Gambhira; Rongcun Yang; Mitsuo Tagaya; Peter M Howley; Patricio I Meneses
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

9.  Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies.

Authors:  N D Christensen; J Dillner; C Eklund; J J Carter; G C Wipf; C A Reed; N M Cladel; D A Galloway
Journal:  Virology       Date:  1996-09-01       Impact factor: 3.616

10.  Papillomavirus assembly requires trimerization of the major capsid protein by disulfides between two highly conserved cysteines.

Authors:  M Sapp; C Fligge; I Petzak; J R Harris; R E Streeck
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more
  7 in total

Review 1.  The evolving field of human papillomavirus receptor research: a review of binding and entry.

Authors:  Adam B Raff; Andrew W Woodham; Laura M Raff; Joseph G Skeate; Lisa Yan; Diane M Da Silva; Mario Schelhaas; W Martin Kast
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

2.  Structural comparison of four different antibodies interacting with human papillomavirus 16 and mechanisms of neutralization.

Authors:  Jian Guan; Stephanie M Bywaters; Sarah A Brendle; Hyunwook Lee; Robert E Ashley; Alexander M Makhov; James F Conway; Neil D Christensen; Susan Hafenstein
Journal:  Virology       Date:  2015-05-19       Impact factor: 3.616

3.  Human papillomavirus type 18 chimeras containing the L2/L1 capsid genes from evolutionarily diverse papillomavirus types generate infectious virus.

Authors:  Brian S Bowser; Horng-Shen Chen; Michael J Conway; Neil D Christensen; Craig Meyers
Journal:  Virus Res       Date:  2011-07-06       Impact factor: 3.303

4.  A Cell-Free Assembly System for Generating Infectious Human Papillomavirus 16 Capsids Implicates a Size Discrimination Mechanism for Preferential Viral Genome Packaging.

Authors:  Carla Cerqueira; Yuk-Ying S Pang; Patricia M Day; Cynthia D Thompson; Christopher B Buck; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

5.  Mutations in HPV18 E1^E4 Impact Virus Capsid Assembly, Infectivity Competence, and Maturation.

Authors:  Jennifer Biryukov; Jocelyn C Myers; Margaret E McLaughlin-Drubin; Heather M Griffin; Janice Milici; John Doorbar; Craig Meyers
Journal:  Viruses       Date:  2017-12-19       Impact factor: 5.048

6.  Efficient Production of Papillomavirus Gene Delivery Vectors in Defined In Vitro Reactions.

Authors:  Carla Cerqueira; Cynthia D Thompson; Patricia M Day; Yuk-Ying S Pang; Douglas R Lowy; John T Schiller
Journal:  Mol Ther Methods Clin Dev       Date:  2017-04-19       Impact factor: 6.698

Review 7.  Papillomavirus Infectious Pathways: A Comparison of Systems.

Authors:  Jennifer Biryukov; Craig Meyers
Journal:  Viruses       Date:  2015-08-04       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.